Curaleaf Holdings, Inc. operates as a vertically integrated multi-state cannabis operator in the United States and has an expanding international presence, particularly in Europe. The company's business model encompasses the entire cannabis supply chain, from cultivation and manufacturing to retail and wholesale distribution. Curaleaf produces a wide range of cannabis products, including flower, pre-rolls, vaporizers, edibles, and topicals, marketed under brands such as Curaleaf, Select, and Grassroots. Geographically, the company operates in numerous U.S. states with significant footprints in markets like Florida, New York, New Jersey, and Pennsylvania, while its "Curaleaf International" division targets European markets like Germany and the U.K. In 2023, Curaleaf generated approximately $1.35 billion in total revenue. The revenue is primarily driven by its retail segment, which accounts for roughly 80% of total sales through its network of over 150 dispensaries, while the wholesale segment contributes the remaining 20%. Competitively, Curaleaf leverages its massive scale, extensive retail footprint, and strategic acquisitions to maintain its position as one of the largest cannabis companies globally by market capitalization and revenue.
